Cargando…
Contraception with estradiol valerate and dienogest: adherence to the method
Purpose: The aim of the study was to examine the discontinuation rate of hormonal contraception with estradiol valerate (E2V) and dienogest (DNG). Patients and methods: We collected data at the Family Planning Clinics of the Departments of Obstetrics and Gynecology of Pisa and Cagliari. We included...
Autores principales: | Fruzzetti, Franca, Paoletti, Anna Maria, Fidecicchi, Tiziana, Posar, Giulia, Giannini, Riccardo, Gambacciani, Marco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6520479/ https://www.ncbi.nlm.nih.gov/pubmed/31191048 http://dx.doi.org/10.2147/OAJC.S204655 |
Ejemplares similares
-
An overview of the development of combined oral contraceptives containing estradiol: focus on estradiol valerate/dienogest
por: Fruzzetti, Franca, et al.
Publicado: (2012) -
Endometrial safety of an oral contraceptive containing estradiol valerate and dienogest
por: Bitzer, Johannes, et al.
Publicado: (2011) -
Estradiol valerate and dienogest: a new approach to oral contraception
por: Kiley, Jessica W, et al.
Publicado: (2011) -
Novel oral contraceptive for heavy menstrual bleeding: estradiol valerate and dienogest
por: Rafie, Sally, et al.
Publicado: (2013) -
Noncontraceptive benefits of the estradiol valerate/dienogest combined oral contraceptive: a review of the literature
por: Nappi, Rossella E, et al.
Publicado: (2014)